Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies

Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies

US Patent 11976293 · Granted May 7, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene editing of monogenic disorders in human hematopoietic stem cells—correction2025
Gene editing of monogenic disorders in human hematopoietic stem cells—correction2025
T cell receptors recognizing HLA-A1-restricted MAGE-A32025
Self-inactivating lentiviral vector comprising a FOXP3 expression cassette2024
Self-inactivating lentiviral vector comprising a FOXP3 expression cassette2024
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and2024
T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage2022
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and2021
Anti-SSX-2 T cell receptors and related materials and methods of use2020
Method for treating adenosine deaminase severe combined imunodeficiency2020
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and2020
Murine anti-NY-ESO-1 T cell receptors2019